| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.00061 | 1 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.0007 | 1 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.00069 | 1 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.0007 | 1 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.0028 | 1 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.0028 | 1 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.00024 | 1 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.00034 | 1 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.00025 | 1 |